Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Ding, Li, Bailey, Matthew H., Porta-Pardo, Eduard, Thorsson, Vesteinn, Colaprico, Antonio, Bertrand, Denis, Gibbs, David L., Weerasinghe, Amila +751 more·2018·Cell

Cited by (416)

Items 301–400 of 416

  1. Pan-cancer evolution signatures link clonal expansion to dynamic changes in the tumor immune microenvironment
    Xinyu Yang, Wei Liu, Geoff Macintyre, Peter Van Loo, Florian M. Markowetz, Peter J. Bailey, Ke Yuan · 2026 · Cell Reports
  2. Combinatory Effects of Indoximod and Melatonin Alleviate Myeloid Derived Suppressor Cells Driven Triple Negative Breast Cancer Progression and Metastasis
    Ece Oylumlu, Sendegül Yıldırım, Aleyna Gezen, Emine Yazıcı, Merzuka Kalay, Sayra Dilmaç, Gamze Güney Eskiler, Gamze Tanrιöver · 2026 · Journal of Pineal Research
  3. H2BE113K mutation promotes breast cancer metastasis through modulating chromatin dynamics
    Shiman Hu (胡诗曼), Jiaxian Liu, Jiaqi Zhou, J Y Chen, Tiantian Qin, Yi Ching Esther Wan, Xiaoxuan Zhu, Danyi Wang, Chuting Shao, Yabin Chen et al. · 2026 · Science Advances
  4. restfulSE: A semantically rich interface for cloud-scale genomics with Bioconductor
    Shweta Gopaulakrishnan, Samuela J Pollack, Benjamin J. Stubbs, Hervé Pagès, John Readey, Sean R. Davis, Levi Waldron, Martin T. Morgan, Vincent J. Carey · 2019 · F1000Research
  5. Genomic Applications in Thyroid Cancer
    Thomas J. Giordano · 2018 · Springer eBooks
  6. The Pan-Cancer Atlas: a New Chapter in Cancer Molecular Targeting Therapy
    Haoliang Hu, Dan-Dan Zeng, Jinglei Zang, Zhe Chen · 2019 · Pathology & Oncology Research
  7. TumorSelect® Technology Enhancing the Safety and Efficacy of Cancer Chemotherapy
    Steve J. Bannister, Amir E. Wahba, Mahesh Kumar Gundluru, Igor Nikoulin, Douglas L. Rodenburg, Michael L. Coen, David A. Lewis, Patrice Penfornis, Pier Paolo Claudio, James Dewey McChesney · 2021 · Research Square
  8. MMR Deficiency Defines Distinct Molecular Subtype of Breast Cancer with Unique Proteomic Networks and Variable Clinical Significance
    Sean M. Hacking, Charissa J. Chou, Yiğit Baykara, Yihong Wang, Alper Uzun, Ece Dilber Gamsiz Uzun · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  9. Missense mutations in the calcium-activated chloride channel TMEM16A promote tumor growth by activating oncogenic signaling in Human Cancer
    Silvia Cruz‐Rangel, Jose Juan De Jesus-Perez, Avani Gopalkrishnan, Roberto Gomez-Casal, Jonathan E. Pacheco, Maya R Brown, Abdul Yassin‐Kassab, Gerald R. V. Hammond, Carol A. Bertrand, Jorge Arreola et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Predictive Modeling of Novel Somatic Mutation Impacts on Cancer Prognosis: A Machine Learning Approach Using the COSMIC Database
    Masab A. Mansoor · 2024 · medRxiv
  11. Inferring clonal composition from multiple tumor biopsies
    Matteo Manica, Hyunjae Ryan Kim, Roland Mathis, Philippe Chouvarine, Dorothea Rutishauser, Laura De Vargas Roditi, Bence Szalai, Ulrich Wagner, Kathrin Oehl, Karim Saba et al. · 2020 · npj Systems Biology and Applications
  12. Bayesian Item Response Theory for Cancer Biomarker Discovery
    Katabathula Ramachandra Murthy, Salendra Singh, David P. Tuck, Vinay Varadan · 2018 · Handbook of statistics
  13. SUMMIT
    Armelle Luscan, Éric Pasmant · 2018 · médecine/sciences
  14. Enjeux et difficultés de la gestion des médicaments onéreux non intégrés dans la liste en sus pour un hôpital traitant des cancers
    Jean‐Yves Blay, David Pérol, Thomas Bachelot, Philippe Zrounba, Pierre Méeus, Sophie Beaupère, Bertrand Favier · 2018 · Bulletin de l Académie Nationale de Médecine
  15. An integrative approach uncovers genes with perturbed interactions in cancers
    Shilpa N. Kobren, Bernard Chazelle, Mona Singh · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Integrated Machine Learning and Bioinformatics Approaches for Prediction of Cancer-Driving Gene Mutations
    Oluyemi Odeyemi · 2020 · Chapman University Digital Commons (Chapman University)
  17. Clinical exome sequencing identified POLB c.C1002A as a possible genetic cause in a family with hereditary cancer-predisposing syndrome
    Zhenxin Zhu, Jieshi Wang, Lisha Jiang, Ling Lin, Peng Meng, Jiangman Zhao, Qingping Cai · 2020 · Cancer Genetics
  18. Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in IDH1/2-wild-type glioblastoma
    Hua Zhao, Xiuming Zhou, Jing Wang, Fanfan Chen, Chang-Peng Wu, Peng‐yu Diao, Lin-rong Cai, Lei Chen, Yanwen Xu, Jing Liu et al. · 2021 · Research Square
  19. Opportunities and Perspectives of NGS Applications in Cancer Research
    Christian Molina‐Aguilar, Martha Estefania Vázquez‐Cruz, Rebeca Olvera-León, Carla Daniela Robles‐Espinoza · 2021 · Learning materials in biosciences
  20. Pan-cancer landscape of AID-related mutations, composite mutations and its potential role in the ICI response
    Isaias Hernández-Verdín, Kadir Caner Akdemir, Daniele Ramazzotti, Giulio Caravagna, Karim Labrèche, Karima Mokhtari, Khê Hoang‐Xuan, Matthieu Peyre, Franck Bielle, Mehdi Touat et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Comprehensive comparison of immune features between ultra-low and ultra-high mutation burden non-small cell lung cancers
    Zhigang Wang, Zhaojun Duan, Chong Chen, Xiaoyin Bai, Wei Liu, Yongqun Oliver He, Xiaolin Yang, Bo Yeun Yang · 2020
  22. Leveraging Summary Statistics and Integrative Analysis for Prediction and Inference in Genome-Wide Association Studies
    Jack W. Pattee · 2020 · University of Minnesota Digital Conservancy (University of Minnesota)
  23. Genomics-based Precision Medicine for Patients with Cancer
    Joris van de Haar · 2021
  24. Molecular Characterization, Via Next-Generation Sequencing, of Refractory or Resistant Invasive Breast Carcinoma
    Patricia Pose Lapausa, Teresa Soria-Comes, Inés Calabria, Inmaculada Maestu · 2021 · Cureus
  25. Identification of Molecular Biomarkers Associated with Non-Small-Cell Lung Carcinoma (NSCLC) Using Whole-Exome Sequencing Analysis
    Varsha Singh, Amit Katiyar, Prabhat Singh Malik, Sunil Kumar, Anant Mohan, Harpreet Singh, Deepali Jain · 2021 · Research Square
  26. Systematic overview of challenges and opportunities of computational data-driven research in biology
    Tejasvene Ramesh, Karishma Chhugani, Vanessa D. Jönsson, Serghei Mangul · 2020
  27. Peer Review #2 of "RITAN: rapid integration of term annotation and network resources (v0.1)"
    2019 · PeerJ
  28. Peer Review #1 of "RITAN: rapid integration of term annotation and network resources (v0.2)"
    2019 · PeerJ
  29. Peer Review #1 of "RITAN: rapid integration of term annotation and network resources (v0.1)"
    2019 · PeerJ
  30. Peer Review #2 of "RITAN: rapid integration of term annotation and network resources (v0.2)"
    2019 · PeerJ
  31. Comprehensive comparison of immune features between ultra-low and ultra-high mutation burden non-small cell lung cancers
    Zhigang Wang, Zhaojun Duan, Chong Chen, Xiaoyin Bai, Wei Liu, Dechao Bu, Jiancheng Luo, Yongqun Oliver He, Xiaolin Yang, Bo Yeun Yang · 2020
  32. Widespread perturbation of ETS factor binding sites in cancer
    Sebastian Carrasco Pro, Heather Hook, D Bray, Daniel Berenzy, Devlin C. Moyer, M Yin, Adam Thomas Labadorf, Ryan Tewhey, Trevor Siggers, Juan I. Fuxman Bass · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  33. The MLL3/TP53/PIK3CA cancer driver mutations promote HIF1α-dependent recruitment and differentiation of pro-tumor ICOS hi GITR hi Blimp-1 + effector regulatory T cells in breast tumors
    Marie Boutet, Kenta Nishitani, Piril Erler, Nicole Couturier, Zheng Zhang, Anna Maria Militello, Marcelo Coutinho de Miranda, Emeline Barbieux, Erik Guillen, Masako Suzuki et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  34. Biología de sistemas y computacional en cáncer: de lo básico a la próxima frontera
    Andrés Felipe Cardona, Luis Eduardo Pino, Erick Andrés Cantor · 2022 · Medicina
  35. O Uso do Sequenciamento Total do Exoma no Diagnóstico do Adenocarcinoma Ductal Pancreático
    Jacques de Oliveira Bernardes, Guilherme Toledo‐Silva · 2023 · Revista Brasileira de Cancerologia
  36. Cancer Therapy
    Wolfgang A. Schulz · 2023 · Springer eBooks
  37. LINC00261 expression reduces mutation accumulation while conferring resistance to cisplatin and altering the tumor-immune microenvironment in lung adenocarcinoma
    Jonathan Castillo, Tianchun Xue, Samantha Joseph, Mayela Norwood, Daniel J. Mullen, Stephanie Berrellez, Sophia James, Alan L. Epstein, Troy A. McEachron, Crystal N. Marconett · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  38. What is the impact of ITGβ8 on NSCLC: A systematic study
    Zhao Jin, Zonglin Jiao, Lei Song, Haitao Wang, Yu Zhang, Yanbin Zhao, Minghui Zhang · 2023 · Research Square
  39. Prognostic implication of ITGB8 and its relationship with immune response
    Zhao Jin, Zonglin Jiao, Lei Song, Yu Zhang, Minghui Zhang, Yanbin Zhao · 2023 · Research Square
  40. Germline and somatic drivers in inherited hematologic malignancies
    Julian Zoller, Despina Trajanova, Simone K. Feurstein · 2023 · Frontiers in Oncology
  41. Radiomics and Radiogenomics Platforms Integrating Machine Learning Techniques: A Review
    Rafael Oliveira, Beatriz Martinho, Ana Vieira, Nelson Pacheco Rocha · 2024 · Lecture notes in networks and systems
  42. Krebstherapie
    Wolfgang A. Schulz · 2024 · Springer eBooks
  43. Additional file 3 of Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer
    Nannan Liu, Yun Wu, Weipeng Cheng, Yuxuan Wu, Liguo Wang, Liwei Zhuang · 2021 · Figshare
  44. Additional file 3 of Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression
    Xu Liu, Yao Li, Jingkun Qu, Lin Liu, Ning Lü, Jiansheng Wang, Jia Zhang · 2021 · Figshare
  45. Additional file 2 of Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer
    Nannan Liu, Yun Wu, Weipeng Cheng, Yuxuan Wu, Liguo Wang, Liwei Zhuang · 2021 · Figshare
  46. Additional file 6 of Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets
    Yangying Zhou, T. Mamie Lih, Jianbo Pan, Naseruddin Höti, Mingming Dong, Liwei Cao, Yingwei Hu, Kyung-Cho Cho, Shao‐Yung Chen, Rodrigo Vargas Eguez et al. · 2020 · Figshare
  47. Additional file 5 of Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets
    Yangying Zhou, T. Mamie Lih, Jianbo Pan, Naseruddin Höti, Mingming Dong, Liwei Cao, Yingwei Hu, Kyung-Cho Cho, Shao‐Yung Chen, Rodrigo Vargas Eguez et al. · 2020 · Figshare
  48. Additional file 2 of Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression
    Xu Liu, Li Yao, Jingkun Qu, Lin Liu, Ning Lü, Jiansheng Wang, Jia Zhang · 2021 · Figshare
  49. Additional file 3 of Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma
    Hongjin Wu, Weiwei Tian, Xiang Tai, Li, Xuanpeng, Ziwei Li, Jing Shui, Juehua Yu, Zhihua Wang, Xiaosong Zhu · 2021 · Figshare
  50. Additional file 1 of Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression
    Xu Liu, Yao Li, Jingkun Qu, Lin Liu, Lu, Ning, Jiansheng Wang, Jia Zhang · 2021 · Figshare
  51. Additional file 4 of Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression
    Xu Liu, Yao Li, Jingkun Qu, Lin Liu, Ning Lü, Jiansheng Wang, Jia Zhang · 2021 · Figshare
  52. Additional file 5 of Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma
    Hongjin Wu, Tian, Weiwei, Xiang Tai, Li, Xuanpeng, Ziwei Li, Jing Shui, Juehua Yu, Zhihua Wang, Xiaosong Zhu · 2021 · Figshare
  53. Additional file 3 of Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets
    Yangying Zhou, T. Mamie Lih, Jianbo Pan, Naseruddin Höti, Mingming Dong, Liwei Cao, Yingwei Hu, Kyung-Cho Cho, Shao‐Yung Chen, Rodrigo Vargas Eguez et al. · 2020 · Figshare
  54. Additional file 3 of Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma
    Rui Zhang, Qi Li, Jialu Fu, Zhechuan Jin, Jingbo Su, Jian Zhang, Chen Chen, Zhimin Geng, Dong Zhang · 2021 · Figshare
  55. Additional file 7 of Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets
    Yangying Zhou, T. Mamie Lih, Jianbo Pan, Naseruddin Höti, Mingming Dong, Liwei Cao, Yingwei Hu, Kyung-Cho Cho, Shao‐Yung Chen, Rodrigo Vargas Eguez et al. · 2020 · Figshare
  56. Additional file 4 of Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets
    Yangying Zhou, T. Mamie Lih, Jianbo Pan, Naseruddin Höti, Mingming Dong, Liwei Cao, Yingwei Hu, Kyung-Cho Cho, Shao‐Yung Chen, Rodrigo Vargas Eguez et al. · 2020 · Figshare
  57. Additional file 2 of Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets
    Yangying Zhou, T. Mamie Lih, Jianbo Pan, Naseruddin Höti, Mingming Dong, Liwei Cao, Yingwei Hu, Kyung-Cho Cho, Shao‐Yung Chen, Rodrigo Vargas Eguez et al. · 2020 · Figshare
  58. Additional file 6 of Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma
    Hongjin Wu, Weiwei Tian, Xiang Tai, Li, Xuanpeng, Ziwei Li, Jing Shui, Juehua Yu, Wang, Zhihua, Xiaosong Zhu · 2021 · Figshare
  59. Additional file 7 of Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma
    Hongjin Wu, Tian, Weiwei, Xiang Tai, Li, Xuanpeng, Ziwei Li, Jing Shui, Juehua Yu, Wang, Zhihua, Xiaosong Zhu · 2021 · Figshare
  60. Additional file 4 of Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma
    Hongjin Wu, Weiwei Tian, Xiang Tai, Li, Xuanpeng, Ziwei Li, Jing Shui, Juehua Yu, Wang, Zhihua, Xiaosong Zhu · 2021 · Figshare
  61. A IMPORTÂNCIA DOS TESTES GENÉTICOS NO DIAGNÓSTICO PRECOCE DO CÂNCER: AVANÇOS, DESAFIOS E PERSPECTIVAS FUTURAS
    Tereza Raquel Xavier Viana, Juliana Isquierdo Miron, Regiane Priscila Ratti, Larissa Teodoro Rabi · 2024 · Editora Omnis Scietia eBooks
  62. Paradigm shifts of life science research in China: Challenges and coping strategies
    Hongliang Zhang · 2024 · 中国科学通报:英文版
  63. Probabilistic graph-based model uncovers previously unseen druggable vulnerabilities in major solid cancers
    Ying Zhu, Stephanie Schmidt, Li Zhao, Chunjie Jiang, Patrizio Di Micco, Costas Mitsopoulos, P. Andrew Futreal, Bissan Al‐Lazikani · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  64. Network modeling links kidney developmental programs and the cancer type-specificity of VHL mutations
    Xiaobao Dong, Donglei Zhang, Xian Zhang, Yan Liu, Yuanyuan Liu · 2024 · npj Systems Biology and Applications
  65. How Have Massively Parallel Sequencing Technologies Furthered Our Understanding of Oncogenesis and Cancer Progression?
    Diogo Ann Onuselogu, Saskia Benz, Suparna Mitra · 2024 · Methods in molecular biology
  66. FROM CANCER MOLECULAR SUBTYPE TO AI HYPE: BENCHMARKING AI IN CANCER MOLECULAR SUBTYPING
    Ahtisham Fazeel Abbasi, Muhammad Sajjad, Muhammad Nabeel Asim, Sebastian J. Vollmer, Andreas R. Dengel · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Paradigm shift in life science research: challenges and <?A3B2 pi6?>coping strategies
    Hongliang Zhang · 2025 · Scientia Sinica Vitae
  68. An Overview of Analytical Approaches to Cancer Proteogenomics
    Chad J. Creighton · 2025 · Methods in molecular biology
  69. Prevalence and impact of molecular variation in the three-prime repair exonuclease 1 TREX1 and its implications for oncology
    Marwa Shekfeh, Mariam M. Konaté, Julia Krushkal · 2025 · Human Genomics
  70. Comparison of genetic mutations in bladder cancers that arose following radiotherapy for prostate cancer with those in primary bladder cancers
    Shogo Adomi, Kazuko Sakai, Yurie Kura, Marco Antonio De Velasco, Saizo Fujimoto, Shingo Toyoda, Mamoru Hashimoto, Mitsuhisa Nishimoto, Eri Banno, Yoshitaka Saito et al. · 2025 · Scientific Reports
  71. Multigene germline and somatic testing for epithelial ovarian cancer in China
    Lei Li, Jianwei Zhang, Nan Song, Bao Sun, Depu Zhang, Liang Li, Yunong Gao, Kui Wu, Qingshui Li, Cong Lin et al. · 2025 · npj Precision Oncology
  72. RIPPLET: Mutation-Only Gene and Pathway Profiling for Precision Oncology
    Fabius Wiesmann, Cassandra Litchfield, Maud Mayoux, Andreas N. WICKI, Burkhard Becher, Viktor Hendrik Koelzer, Holger Moch, Marija Buljan, Sònia Tugues, Bettina Sobottka · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  73. The power of connection—enabling collaborative, multimodal data analysis at petabyte scale to advance understanding of oncology
    Brandi N. Davis‐Dusenbery, Cera R. Fisher, Rowan Beck, Zelia Worman · 2025 · Oxford University Press eBooks
  74. Precision Medicine and Computational Cytology
    Pranab Dey · 2025 · Springer eBooks
  75. Graph Neural Networks for Cancer Mutation Analysis: A Deep Learning Approach for Biomarker Identification in Breast Cancer
    Juan Valentin Boyer, Jaafar M. Alghazo, Wordh Ul Hasan · 2025 · IEEE International Conference on Imaging Systems and Techniques (IST)
  76. Transposable elements in human cancer: Regulation, activation, and genomic consequences
    Layla Diaz-Portal, Jesús Emiliano Sotelo-Fonseca, Bernardo Rodriguez-Martin · 2025 · Advances in genetics
  77. Additional file 5 of Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression
    Liu, Xu, Yao, Li, Qu, Jingkun, Liu, Lin, Lu, Ning, Jiansheng Wang, Zhang, Jia · 2021 · Figshare
  78. Additional file 1 of Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma
    Wu, Hongjin, Tian, Weiwei, Xiang Tai, Li, Xuanpeng, Li, Ziwei, Jing Shui, Yu, Juehua, Wang, Zhihua, Xiaosong Zhu · 2021 · Figshare
  79. Additional file 2 of Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma
    Zhang, Rui, Li, Qi, Fu, Jialu, Zhechuan Jin, Jingbo Su, Zhang, Jian, Chen, Chen, Geng, Zhimin, Zhang, Dong · 2021 · Figshare
  80. Additional file 1 of Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma
    R Zhang, Li, Qi, Fu, Jialu, Zhechuan Jin, Jingbo Su, Zhang, Jian, Chen, Chen, Geng, Zhimin, Zhang, Dong · 2021 · Figshare
  81. Additional file 1 of Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients
    Zhao, Hua-fu, Zhou, Xiu-ming, Wang, Jing, Chen, Fan-fan, Wu, Chang-peng, Diao, Peng-yu, Cai, Lin-rong, Chen, Lei, Xu, Yan-wen, Jing Liu et al. · 2021 · Figshare
  82. Additional file 1 of Pan-cancer analysis reveals tumor-associated macrophage communication in the tumor microenvironment
    Wang, Linbang, He, Tao, Liu, Jingkun, Jiaojiao Tai, Wang, Bing, Chen, Zhiyu, Quan Zhengxue · 2021 · Figshare
  83. Additional file 7 of Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression
    Liu, Xu, Yao, Li, Qu, Jingkun, Liu, Lin, Lu, Ning, Jiansheng Wang, Zhang, Jia · 2021 · Figshare
  84. Additional file 1 of Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer
    Liu, Nannan, Wu, Yun, Weipeng Cheng, Wu, Yuxuan, Wang, Liguo, Zhuang, Liwei · 2021 · Figshare
  85. Additional file 1 of Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets
    Zhou, Yangying, T. Mamie Lih, Pan, Jianbo, Naseruddin Höti, Dong, Mingming, Cao, Liwei, Yingwei Hu, Cho, Kyung-Cho, Chen, Shao-Yung, Eguez, Rodrigo Vargas et al. · 2020 · Figshare
  86. Additional file 9 of Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression
    Liu, Xu, Yao, Li, Qu, Jingkun, Liu, Lin, Lu, Ning, Jiansheng Wang, Zhang, Jia · 2021 · Figshare
  87. Additional file 8 of Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression
    Liu, Xu, Yao, Li, Qu, Jingkun, Liu, Lin, Lu, Ning, Jiansheng Wang, Zhang, Jia · 2021 · Figshare
  88. Additional file 6 of Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report
    Ana Mordoh, Triviño Pardo, Juan Carlos, Ibel Carri, María Marcela Barrio, José Mordoh, Mariana Aris · 2023 · Figshare
  89. Additional file 4 of Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma
    Zhang, Rui, Li, Qi, Fu, Jialu, Zhechuan Jin, Jingbo Su, Zhang, Jian, Chen, Chen, Geng, Zhimin, Zhang, Dong · 2021 · Figshare
  90. Additional file 5 of Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma
    Zhang, Rui, Li, Qi, Fu, Jialu, Zhechuan Jin, Jingbo Su, Zhang, Jian, Chen, Chen, Geng, Zhimin, Zhang, Dong · 2021 · Figshare
  91. Additional file 10 of Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression
    Liu, Xu, Yao, Li, Qu, Jingkun, Liu, Lin, Lu, Ning, Jiansheng Wang, Zhang, Jia · 2021 · Figshare
  92. Additional file 5 of Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report
    Ana Mordoh, Triviño Pardo, Juan Carlos, Ibel Carri, María Marcela Barrio, José Mordoh, Mariana Aris · 2023 · Figshare
  93. Additional file 1 of SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy
    Zheng, Xiaobin, Lin, Jing, Xiong, Jiani, Guan, Yanfang, Lan, Bin, Li, Yi, Gao, Xuan, Zhaodong Fei, Chen, Lisha, Lizhu Chen et al. · 2024 · Figshare
  94. Additional file 1 of Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report
    Ana Mordoh, Triviño Pardo, Juan Carlos, Ibel Carri, María Marcela Barrio, José Mordoh, Mariana Aris · 2023 · Figshare
  95. Additional file 2 of Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma
    Wu, Hongjin, Tian, Weiwei, Xiang Tai, Li, Xuanpeng, Li, Ziwei, Jing Shui, Yu, Juehua, Wang, Zhihua, Xiaosong Zhu · 2021 · Figshare
  96. Additional file 7 of Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report
    Ana Mordoh, Triviño Pardo, Juan Carlos, Ibel Carri, María Marcela Barrio, José Mordoh, Mariana Aris · 2023 · Figshare
  97. Additional file 1 of OnkoRiskNET: a multicenter, interdisciplinary, telemedicine-based model to improve care for patients with a genetic tumor risk syndrome
    Johanna Tecklenburg, Beate Vajen, Susanne Morlot, Anders, Petra, Paula Memenga, Link, Elena, Eva Baumann, Sarah Wölffling, Evelin Schröck, Anke Katharina Bergmann et al. · 2022 · Figshare
  98. Additional file 6 of Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression
    Liu, Xu, Yao, Li, Qu, Jingkun, Liu, Lin, Lu, Ning, Jiansheng Wang, Zhang, Jia · 2021 · Figshare
  99. Additional file 1 of Predicting heterogeneity in clone-specific therapeutic vulnerabilities using single-cell transcriptomic signatures
    Chayaporn Suphavilai, Shumei Chia, Ankur Sharma, Lorna Tu, Da Silva, Rafael Peres, Aanchal Mongia, Ramanuj DasGupta, Nagarajan, Niranjan · 2021 · Figshare
  100. Identification of cancer mini-drivers by deciphering selective landscape in the cancer genome
    Xunuo Zhu, Wen-Yi Zhao, Siqi Wang, Jingwen Yang, Jing-Qi Zhou, Bin-Bin Zhou, Ji Cao, Bo Yang, Zhan Zhou, Xun Gu · 2026 · Briefings Bioinform.